ImmPACT Bio Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
ImmPACT Bio is a clinical-stage biotechnology company focused on developing CAR T-cell therapies for cancer and autoimmune diseases. Its approach aims to distinguish cancer and diseased cells from normal tissue to enable targeted elimination while preserving healthy cells. The company originated in 2017 in Israel's FuturRx incubator, later establishing a U.S. presence in 2019 and merging with Kalthera in 2021. In 2022, ImmPACT Bio relocated its corporate offices to West Hills, California, and built a modern clinical manufacturing facility. The organization is now part of Lyell Immunopharma, indicating its integration within a broader cell-therapy platform.